DexCom stock price target maintained at $100 by Piper Sandler
PositiveFinancial Markets

Piper Sandler has maintained its stock price target for DexCom at $100, reflecting confidence in the company's performance and growth potential in the continuous glucose monitoring market. This stability in target price is significant for investors as it suggests that DexCom is expected to continue its upward trajectory, which could lead to increased investor interest and market activity.
— Curated by the World Pulse Now AI Editorial System